http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-114012-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1005fb53db203969fab84a916931d38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ef33401e844e4f184c336b2c8325e17 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-17 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 |
| filingDate | 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62c3b8ee9d52286f00e62b2041c9cd90 |
| publicationDate | 2020-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-114012-A1 |
| titleOfInvention | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT |
| abstract | This refers to the field of the treatment of an orphan disease, in particular the treatment of vascular Ehlers-Danlos syndrome (vEDS). More specifically, this relates to titre-up dosage regimens (eg, escalating dosage regimens) effective for treating vEDS patients with celiprolol. Claim 1: A method for treating vascular Ehlers-Danlos syndrome, which comprises administering to a patient in need thereof a daily dose of 80 to 100 mg of celiprolol, or an equivalent amount of a pharmaceutically acceptable salt thereof, and increasing the daily dose up to 360 to 440 mg within six months. |
| priorityDate | 2017-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553031 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2663 |
Total number of triples: 16.